We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Intervacc AB (IVACC) NPV

Sell:4.14 SEK Buy:4.15 SEK Change: 0.04 SEK (0.97%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Sell:4.14 SEK
Buy:4.15 SEK
Change: 0.04 SEK (0.97%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Sell:4.14 SEK
Buy:4.15 SEK
Change: 0.04 SEK (0.97%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The Company operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. It offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.

Contact details

Address:
Vastertorpsvagen 135
HAGERSTEN
129 44
Sweden
Telephone:
+46 (8) 12010600
Website:
intervacc.se/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IVACC
ISIN:
SE0009607252
Market cap:
310.90 million SEK
Shares in issue:
75.74 million
Sector:
Biotechnology
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Hakan Bjorklund
    Chairman of the Board
  • Jonas Sohlman
    Chief Executive Officer
  • Jan Persson
    Chief Financial Officer
  • Patrik Hellberg
    Chief Information Officer
  • Andreas Johansson
    Vice President - Supply Chain Management
  • Tim Wood
    Vice President - CMC and Regulatory
  • Andrew Waller
    CSO

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.